Platelet-rich plasma therapy in dogs with bilateral hip osteoarthritis
- PMID: 34090433
- PMCID: PMC8180029
- DOI: 10.1186/s12917-021-02913-x
Platelet-rich plasma therapy in dogs with bilateral hip osteoarthritis
Abstract
Background: Osteoarthritis (OA) is the most commonly diagnosed joint disease in companion animals, and hip OA is commonly diagnosed in the canine population. The use of platelet-rich plasma has gained increasing interest for the treatment of musculoskeletal conditions in companion animals. To evaluate the effect of the intra-articular administration of platelet-rich plasma in police working dogs with bilateral hip OA compared to a control group, twenty dogs were assigned to a control group (CG, n = 10) or treatment group (PG, n = 10), using the statistical analysis software. PG received two intra-articular administrations of platelet-rich plasma, 14 days apart, while CG received an intra-articular administration of saline, in the same moments. Response to treatment was determined with the Canine Brief Pain Inventory, Liverpool Osteoarthritis in Dogs, Canine Orthopedic Index, and Hudson Visual Analogue Scale, before treatment, + 8, + 15, + 30, + 60, + 90, + 120, 150, and + 180 days after initial treatment. Kaplan-Meier estimators were conducted and compared with the log-rank test. Cox proportional hazard regression analysis was performed to determine treatment survival, p < 0.05.
Results: The sample comprised 20 animals of both sexes (male n = 12, female n = 8), with a mean age of 8.4 ± 2.4 years and a bodyweight of 31.5 ± 5.7 kg. Joints were classified as moderate (13) and severe (7) according to the Orthopedic Foundation for Animals grading scheme. No differences were found between groups at the initial evaluation. Better results with the majority of scores were observed in the PG, in some cases lasting up to the last evaluation moment. Kaplan-Meier estimators showed that PG produced longer periods with better results in all scores compared to CG. Treatment was the covariate influencing all scores in the Cox regression analysis. OFA hip score also influenced two dimensions of the Canine Orthopedic Index.
Conclusion: The intra-articular administration of platelet-rich plasma can improve pain and functional scores of police working dogs with bilateral hip OA, compared with a control group. Its effects lasted for significantly longer periods, and treatment was the main covariate affecting the improvements observed.
Keywords: Dog; Hip; Osteoarthritis; Pain; Platelet-rich plasma; Regenerative therapy.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures


Similar articles
-
A first report on the efficacy of a single intra-articular administration of blood cell secretome, triamcinolone acetonide, and the combination of both in dogs with osteoarthritis.BMC Vet Res. 2022 Aug 13;18(1):309. doi: 10.1186/s12917-022-03413-2. BMC Vet Res. 2022. PMID: 35962448 Free PMC article.
-
Clinical and diagnostic imaging findings in police working dogs referred for hip osteoarthritis.BMC Vet Res. 2020 Nov 7;16(1):425. doi: 10.1186/s12917-020-02647-2. BMC Vet Res. 2020. PMID: 33160336 Free PMC article.
-
Intra-articular Injections With Either Triamcinolone Hexacetonide, Stanozolol, Hylan G-F 20, or a Platelet Concentrate Improve Clinical Signs in Police Working Dogs With Bilateral Hip Osteoarthritis.Front Vet Sci. 2021 Jan 18;7:609889. doi: 10.3389/fvets.2020.609889. eCollection 2020. Front Vet Sci. 2021. Retraction in: Front Vet Sci. 2023 Jan 18;9:1130041. doi: 10.3389/fvets.2022.1130041. PMID: 33537353 Free PMC article. Retracted.
-
Platelet-Rich Plasma for the Management of Hip and Knee Osteoarthritis.Curr Rheumatol Rep. 2017 May;19(5):24. doi: 10.1007/s11926-017-0652-x. Curr Rheumatol Rep. 2017. PMID: 28386761 Review.
-
Administration of mesenchymal stem cells from adipose tissue at the hip joint of dogs with osteoarthritis: A systematic review.Res Vet Sci. 2021 Mar;135:495-503. doi: 10.1016/j.rvsc.2020.11.014. Epub 2020 Nov 24. Res Vet Sci. 2021. PMID: 33280823
Cited by
-
Effect of Leukoreduced Platelet Rich Plasma on Intra-Articular Pro-Inflammatory Cytokines in a Canine Pilot Study.Animals (Basel). 2022 Aug 24;12(17):2163. doi: 10.3390/ani12172163. Animals (Basel). 2022. PMID: 36077884 Free PMC article.
-
A first report on the efficacy of a single intra-articular administration of blood cell secretome, triamcinolone acetonide, and the combination of both in dogs with osteoarthritis.BMC Vet Res. 2022 Aug 13;18(1):309. doi: 10.1186/s12917-022-03413-2. BMC Vet Res. 2022. PMID: 35962448 Free PMC article.
-
Comparative analysis of cytokine profiles in canine injectable platelet-rich fibrin and platelet-rich plasma.Int J Vet Sci Med. 2025 Apr 3;13(1):1-8. doi: 10.1080/23144599.2025.2483104. eCollection 2025. Int J Vet Sci Med. 2025. PMID: 40213115 Free PMC article.
-
A randomised, parallel-group clinical trial comparing bedinvetmab to meloxicam for the management of canine osteoarthritis.Front Vet Sci. 2025 Mar 24;12:1502218. doi: 10.3389/fvets.2025.1502218. eCollection 2025. Front Vet Sci. 2025. PMID: 40196808 Free PMC article.
-
Palmitoyl-glucosamine co-micronized with curcumin for maintenance of meloxicam-induced pain relief in dogs with osteoarthritis pain.BMC Vet Res. 2023 Feb 7;19(1):37. doi: 10.1186/s12917-023-03594-4. BMC Vet Res. 2023. PMID: 36747264 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources